Pittsburgh, PA (PRWEB) December 13, 2013
The Skin Center Medical Spa will be among the first in the Pittsburgh-area to receive JUVEDERM® VOLUMA™ XC, the first and only injectable dermal filler approved in the U.S. to correct age-related volume loss in the cheek area. VOLUMA™ XC received FDA-approval on October 23, 2013, and The Skin Center Medical Spa will be one of a select group of providers nationwide to offer the treatment prior to commercial availability.
Ranked as the top medical spa in Pennsylvania and Ohio, and seventh in the nation by the Allergan Partner Privilege Program (the makers of Voluma™ and Botox® Cosmetic), The Skin Center Medical Spa & Aesthetic Practice will be given a limited amount of Voluma™ XC to treat clients prior to market-wide availability.
Voluma™ XC is the first product of its kind specifically formulated to correct age-related volume loss in the cheek area. As skin ages and loses collagen, cheeks lose volume, often leading to a flattened, sunken or sagging appearance. VOLUMA™ XC is an injectable gel filler that returns youthful volume and smoothness to the cheek area. Results are long-lasting results – up to two years in most cases.
“Voluma™ XC is an exciting innovation in the field of non-surgical cosmetic enhancement. Not only is the long-lasting formulation cost effective for our clients wanting to maintain a naturally youthful look, by delaying the need for invasive surgical options that come with a longer recovery period and time away from work,” said Dominic Brandy, MD, board-certified cosmetic surgeon and founding medical director of The Skin Center Medical Spa. “However, the benefits of a long-lasting injectable filler also comes with a word of caution — it is absolutely necessary to check the credentials of the injector and verify that they have received the appropriate training, and have an understanding of facial anatomy. Otherwise you may be disappointed with the outcome and the lasting results.”
The Skin Center Medical Spa employs expert injectors to administer Juvederm Voluma™ XC, including a National Trainer for Allergan, Inc., the makers of Botox Cosmetic and Voluma™ XC. Debra Thomas, RN, The Skin Center’s National Trainer for Allergan, Inc, travels the country teaching other medical professionals proper injection techniques for the entire family of Juvederm dermal fillers including Voluma™ as well as the most advanced applications for BOTOX® Cosmetic. As such, Thomas will be among one of the first groups trained by Allergan Inc. to inject Voluma™ XC for optimal results.
According to Allergan, Inc., Juvederm Voluma™ XC is made with proprietary VYCROSS™ technology, an advanced manufacturing process that results in a smooth gel that flows easily and consistently. This unique formulation contributes to the lift capacity to correct volume loss in the cheeks and to the duration of the product. Additionally Juvederm Voluma™ XC contains a small amount of lidocaine which helps to numb the treatment area as the product is being injected.
As reported by Allergan Inc., the most common side effects observed in the clinical trial included temporary injection-site tenderness, swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration and itching. They were predominately moderate (uncomfortable) in severity, with a duration of two to four weeks.
For more than 30 years, The Skin Center Medical Spa’s team of board-certified cosmetic surgeons, board-certified plastic surgeons, vascular surgeons and nurses offer women and men advanced cosmetic plastic surgery and minimally invasive treatments for healthier-looking skin, and complete rejuvenation of the face and body.
To learn more about injectable dermal fillers or schedule a Voluma™ XC consultation, call 1-800-429-1151 or visit http://www.skincentermd.com to learn more.